The Gulf Coast Consortium Research Evaluation and Commercialization Hub will support translation of research discoveries to patient care.

The interdisciplinary initiative is funded by a $3 million grant from the National Institutes of Health.

The five-year grant from the National Institutes of Health will support infrastructure to investigate and advance 3D-printed pediatric medications in hospitals.

The Texas A&M research could allow antibiotics to have a greater impact on pathogens.

Research from Texas A&M could untether patients from bulky cuffed devices by applying small strips of graphene to the skin to collect cardiovascular data.

The institute's chair says the grant is a unique opportunity for Texas A&M to advance the careers of a diverse research workforce in neuroscience.

The award will support the development and evaluation of a technology platform that provides resources for caregivers of people living with dementia.

A Texas A&M team's findings could have implications for the treatment of bone regeneration.

Biologist Joseph Sorg is leading a team to analyze C. difficile, which kills at least 29,000 people a year.

The grant will support Stephen Maren's work toward discovering better treatments for individuals with anxiety disorders.